Biomatter

About

Biomatter is a synthetic biology company based in Vilnius, Lithuania, founded in 2018. The company specializes in creating new proteins and enzymes using generative artificial intelligence, focusing on applications in health and sustainable manufacturing. Biomatter's Intelligent Architecture™ platform allows for the design of enzymes from scratch or the redesign of existing proteins, significantly reducing development cycles. Biomatter develops customized enzymes tailored to various industries, including chemical biomanufacturing, agriculture, food, and life sciences. The company collaborates with partners to create purpose-built molecules that meet specific application needs. Notable customers include Thermo Fisher Scientific, BASF, Neogen, Cargill, and Kirin, with a significant project involving the development of enzymes for the industrial-scale production of human milk oligosaccharides, which support infant health. In August 2024, Biomatter raised €6.5 million in seed funding to enhance its generative AI platform for enzyme development.